These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 23463283)
1. CacyBP/SIP enhances multidrug resistance of pancreatic cancer cells by regulation of P-gp and Bcl-2. Chen X; Zheng P; Xue Z; Li J; Wang W; Chen X; Xie F; Yu Z; Ouyang X Apoptosis; 2013 Jul; 18(7):861-9. PubMed ID: 23463283 [TBL] [Abstract][Full Text] [Related]
2. CacyBP/SIP protein promotes proliferation and G1/S transition of human pancreatic cancer cells. Chen X; Mo P; Li X; Zheng P; Zhao L; Xue Z; Ren G; Han G; Wang X; Fan D Mol Carcinog; 2011 Oct; 50(10):804-10. PubMed ID: 21268134 [TBL] [Abstract][Full Text] [Related]
3. Regulation of drug sensitivity of gastric cancer cells by human calcyclin-binding protein (CacyBP). Shi Y; Hu W; Yin F; Sun L; Liu C; Lan M; Fan D Gastric Cancer; 2004; 7(3):160-6. PubMed ID: 15449204 [TBL] [Abstract][Full Text] [Related]
4. Expression and clinical significance of CacyBP/SIP in pancreatic cancer. Chen X; Han G; Zhai H; Zhang F; Wang J; Li X; Huang S; Wang X; Fan D Pancreatology; 2008; 8(4-5):470-7. PubMed ID: 18765951 [TBL] [Abstract][Full Text] [Related]
5. DJ-1 is involved in the multidrug resistance of SGC7901 gastric cancer cells through PTEN/PI3K/Akt/Nrf2 pathway. Qiu L; Ma Z; Li X; Deng Y; Duan G; Zhao LE; Xu X; Xiao L; Liu H; Zhu Z; Chen H Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(11):1202-1214. PubMed ID: 33079995 [TBL] [Abstract][Full Text] [Related]
6. CacyBP/SIP inhibits Doxourbicin-induced apoptosis of glioma cells due to activation of ERK1/2. Tang Y; Zhan W; Cao T; Tang T; Gao Y; Qiu Z; Fu C; Qian F; Yu R; Shi H IUBMB Life; 2016 Mar; 68(3):211-9. PubMed ID: 26825673 [TBL] [Abstract][Full Text] [Related]
7. TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo. Cao J; Yang J; Ramachandran V; Arumugam T; Deng D; Li Z; Xu L; Logsdon CD PLoS One; 2015; 10(12):e0144969. PubMed ID: 26709920 [TBL] [Abstract][Full Text] [Related]
8. CacyBP/SIP nuclear translocation induced by gastrin promotes gastric cancer cell proliferation. Zhai HH; Meng J; Wang JB; Liu ZX; Li YF; Feng SS World J Gastroenterol; 2014 Aug; 20(29):10062-70. PubMed ID: 25110433 [TBL] [Abstract][Full Text] [Related]
9. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway. Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933 [TBL] [Abstract][Full Text] [Related]
10. [The mechanism of resistance to 2', 2'-difluorodeoxycytidine (gemcitabine) in a pancreatic cancer cell line]. Yao J; Feng FY; Lin C; Zhang XY; Fu M; Liang X; Yang Y Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):721-6. PubMed ID: 16483481 [TBL] [Abstract][Full Text] [Related]
11. Effects of the proteasome inhibitor bortezomib on gene expression profiles of pancreatic cancer cells. Tang ZY; Wu YL; Gao SL; Shen HW J Surg Res; 2008 Mar; 145(1):111-23. PubMed ID: 17714734 [TBL] [Abstract][Full Text] [Related]
12. Expression and regulation of CacyBP/SIP in chronic lymphocytic leukemia cell balances of cell proliferation with apoptosis. Fu C; Wan Y; Shi H; Gong Y; Wu Q; Yao Y; Niu M; Li Z; Xu K J Cancer Res Clin Oncol; 2016 Apr; 142(4):741-8. PubMed ID: 26603518 [TBL] [Abstract][Full Text] [Related]
13. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells. Liu F; Liu S; He S; Xie Z; Zu X; Jiang Y Oncol Rep; 2010 May; 23(5):1469-75. PubMed ID: 20372866 [TBL] [Abstract][Full Text] [Related]
14. CacyBP/SIP nuclear translocation regulates p27Kip1 stability in gastric cancer cells. Niu YL; Li YJ; Wang JB; Lu YY; Liu ZX; Feng SS; Hu JG; Zhai HH World J Gastroenterol; 2016 Apr; 22(15):3992-4001. PubMed ID: 27099442 [TBL] [Abstract][Full Text] [Related]
15. CIAPIN1 confers multidrug resistance by upregulating the expression of MDR-1 and MRP-1 in gastric cancer cells. Hao Z; Li X; Qiao T; Du R; Hong L; Fan D Cancer Biol Ther; 2006 Mar; 5(3):261-6. PubMed ID: 16410721 [TBL] [Abstract][Full Text] [Related]
16. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents. Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046 [TBL] [Abstract][Full Text] [Related]
17. Targeting P-glycoprotein and SORCIN: Dihydromyricetin strengthens anti-proliferative efficiency of adriamycin via MAPK/ERK and Ca Sun Y; Wang C; Meng Q; Liu Z; Huo X; Sun P; Sun H; Ma X; Peng J; Liu K J Cell Physiol; 2018 Apr; 233(4):3066-3079. PubMed ID: 28681913 [TBL] [Abstract][Full Text] [Related]
18. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells. Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283 [TBL] [Abstract][Full Text] [Related]
19. Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro. Liu DL; Bu H; Li H; Chen H; Guo HC; Wang ZH; Tong HF; Ni ZL; Liu HB; Lin SZ Int J Oncol; 2012 Apr; 40(4):1049-57. PubMed ID: 22159556 [TBL] [Abstract][Full Text] [Related]
20. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line. Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]